15m
Hosted on MSNPiper Sandler Initiates Coverage of Avalo Therapeutics (AVTX) with Overweight RecommendationFintel reports that on February 28, 2025, Piper Sandler initiated coverage of Avalo Therapeutics (NasdaqCM:AVTX) with a ...
Piper Sandler upgraded CAVA Group (NYSE:CAVA) to an Overweight rating on Friday after having the restaurant stock slotted at ...
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...
Looking at more recent history, Kantrowitz noted that every correction from the late 1990s until 2018 "were all growth-driven market corrections." The two since 2022 have been rates-driven selloffs, ...
Piper Sandler analyst Alexander Goldfarb maintained a Buy rating on Equity Residential (EQR – Research Report) today and set a price target of ...
Handelsbanken Fonder AB lifted its holdings in shares of Piper Sandler Companies (NYSE:PIPR – Free Report) by 13.3% in the ...
The only negative coming out of Nvidia's earnings? Expectations for a 71% adjusted gross margin this quarter as the company continues ahead with its Blackwell ramp, according to Piper Sandler analyst ...
Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...
Nvidia (NASDAQ:NVDA) is in the spotlight ahead of its Q4 earnings, with Evercore ISI and Piper Sandler sticking to their ...
Nvidia (NVDA) was in focus on Tuesday as investment firms Evercore ISI and Piper Sandler issued positive notes on the ...
The Trump administration’s federal mass job cuts may amount to the largest in history. That has financial ramifications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results